All posts by: Michael Zand

About Michael Zand

A new gene therapy may help ‘turn off’ asthma and food allergies – Hindustan Times

Continue reading

2017-06-04 NEWS

Hindustan Times

A new gene therapy may help ‘turn off’ asthma and food allergies
Hindustan Times
Researchers have developed a new gene therapy that may help to ‘turn-off’ the immune response which causes allergic reaction such as asthma, or potentially lethal food allergies, researchers have found. “When someone has an allergy or asthma flare-up, …
New gene therapy may ‘turn off’ asthmaEconomic Times

all 1 news articles »

Continue reading

2017-06-04 NEWS

Chicago Daily Herald

How newly approved immunotherapy is giving some cancer patients hope
Chicago Daily Herald
It showed that immunotherapy could attack colon and other cancers thought to be unstoppable. The key was their tumors’ genetic defect, known as mismatch repair (MMR) deficiency — akin to a missing spell-check on their DNA. As the DNA copies itself

and more »

Continue reading

2017-06-04 NEWS

Salon

Crispr’s Next Big Debate: How Messy Is Too Messy?
WIRED
When it comes to Crispr, the bacterial wünderenzyme that allows scientists to precisely edit DNA, no news is too small to stir up some drama. On Tuesday morning, doctors from Columbia, Stanford, and the University of Iowa published a one-page letter to
CRISPR controversy raises questions about gene-editing technique …Salon
CRISPR Found To Have A Dangerous Side-Effect: Unwanted …Wall Street Pit
Unexpected mutations after CRISPR gene-editing experimentsBioEdge
TrendinTech –Corpus Christi Caller-Times –Good Herald
all 6 news articles »
Continue reading

2017-06-04 NEWS

The Lawton Constitution

Mother considers adult stem cell treatment for son
The Lawton Constitution
But Nation hopes a special experimental adult stem cell treatment could help her son achieve a better quality of life. “In the research I’ve done, 70-85 percent of autistic kids that have undergone this treatment have made extreme improvements in a

Continue reading

2017-06-03 NEWS

Medical Daily

The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be …
EurekAlert (press release)
The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be effective in patients with metastatic triple negative breast cancer, according to an international clinical trial led by NYU Langone’s Perlmutter …
Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New TrialsMedical Daily

all 2 news articles »

Continue reading

2017-06-03 NEWS

Medical Daily

Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer
PR Newswire (press release)
NEW YORK, June 3, 2017 /PRNewswire-USNewswire/ — The immunotherapy drug pembrolizumab—already FDA-approved for other forms of cancer–has been found to be effective in patients with metastatic triple negative breast cancer, according to an …
Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New TrialsMedical Daily

all 2 news articles »